Back to Journals » Drug Design, Development and Therapy » Volume 13

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study

Total article views   HTML views PDF downloads Totals
7,017 Dovepress* 6,310+ 1,188 7,498
PubMed Central* 707 125 832
Totals 7,017 1,313 8,330
*Since 24 January 2019

View citations on PubMed Central and Google Scholar